2 / 61
for
SUSTAINED
CONTROL
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Fax
+27 21 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762) / +27 21 707 7000
www.pharmadynamics.co.zaDYNA GLICLAZIDE SR 30 mg
. Each tablet contains 30 mg gliclazide. S3 A42/21.2/0249. NAM NS2 12/21.2/0110. For full prescribing information, refer to the professional information approved by SAHPRA, 28 July 2017.
1)
Crepaldi G and Fioretto P. Gliclazide modified release: Its place in the therapeutic armamentarium.
Metabolism
2000;49(10)supplement 2:21-25.
2)
McGavin JK,
et al
. Gliclazide modified release.
Drugs
2002;62(9):1357-1364.
*
Conditions apply.
DGLL732/05/2021.
Once daily formulation
Improved compliance
1
Sustained 24 hour glycaemic control
2
60
’
s
Packed in
Within
reference
at major
medical
schemes.
*